Bad karma: we can't find that page!

The Hematology/Oncology Pharmacy Association (HOPA) is pleased to present the HOPA Oncology Pharmacy Practice Management program, taking place September 27 from 7:00 am – 7:00 pm at the Sheraton Chicago O’Hare Airport Hotel, designed to guide oncology pharmacy providers on how to effectively manage the expensive, high risk care and oncology medications they provide, but still allow for the implementation of new technologies, improvement of safety, and adhere to compliance.

Patients at Cincinnati Children's Hospital Medical Center are being exposed to significantly less radiation during CT scans because of new technology that allows doctors to more tightly control radiation doses. The first-of-its-kind imaging software reduced overall radiation exposure from CT scans by 37 percent, according to two new studies published online today in the journal Radiology.

Intraoperative MRI and angiography confirms retinoblastoma chemotherapy treatment

IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") announced that Yale-New Haven Hospital, New Haven, CT, neurosurgeons are confirming effective chemotherapy delivery in treating eye cancer using intraoperative imaging within the VISIUS® Surgical Theatre.

Collaborations With CDC, AHRQ and NCCN Bring Current, Usable Content to the Point of Care

As the provider of the top medical app for U.S. physicians, Epocrates, Inc., an athenahealth company (Nasdaq:ATHN), serves as the conduit for organizations to deliver succinct and actionable content to clinicians at the point of care. The company has expanded collaborations with three industry-leading organizations—Centers for Disease Control and Prevention (CDC), Agency for Healthcare Research and Quality (AHRQ) and National Comprehensive Cancer Network® (NCCN®)—to ensure valuable content is getting into the hands of the more than one million healthcare professionals in the Epocrates member network:

MedCurrent Corporation, a provider of clinical decision support solutions (CDS), announced that it has signed an agreement with the National Decision Support Company (NDSC). MedCurrent customers will have access to ACR Select™, the digitally consumable version of the American College of Radiology (ACR) Appropriateness Criteria®. The ACR Criteria will provide ordering clinicians with evidence based guidelines for selecting the most appropriate imaging study for their patients, assuring the right radiology exam is performed and reducing unnecessary tests and radiation exposure. The appropriateness criteria will be utilized within MedCurrent’s OrderRight, its proprietary decision support user interface.